Evidence map›Paper›PMID 39897193›Full record

ArticleCureus2025

Case Series: Large B-cell Lymphoma With IRF4 Rearrangement Involving the Lung and Tonsil in Two Different Patients.

Ahmed Abdulrahim, Ahmed Sabri, Bryan Teruya, Changzhao Li, David Cantu

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahmed AbdulrahimPathology, Creighton University School of Medicine, Omaha, USA.
Ahmed SabriPathology, University of Nebraska Medical Center, Omaha, USA.
Bryan TeruyaHematopathology, Hematogenix Laboratory Services, Tinley Park, USA.
Changzhao LiDermatopathology, Naples Pathology Associates, Naples, USA.
David CantuPathology, CHI Health Creighton University Medical Center, Omaha, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large B-cell lymphoma (LBCL) with interferon regulatory factor 4 (IRF4) rearrangement is characterized by the monotonous proliferation of medium- to large-sized cells with strong expression of IRF4/multiple myeloma oncogene 1 (MUM1). It predominantly affects children and young adults with a median age of 12. The reported disease sites include head and neck lymph nodes, the Waldeyer's ring, and the gastrointestinal tract. Here, we report two cases of LBCL with IRF4 rearrangement in 73-year-old and 71-year-old patients. The first patient presented with a lung nodule, while the second patient presented with right palatine tonsillitis. To our knowledge, LBCL with IRF4 rearrangement involving the lung in an elderly patient has not been previously reported.

Indexed as

irf4 rearrangementlarge b cell lymphomalymphomanon-hodgkin lymphomatonsilitis

Identifiers

PMID39897193
PMCPMC11785450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.